Abstract
Catecholamine-O-methyl-tranferase (COMT) initiates dopamine degradation. Its activity is mainly determined by a single nucleotide polymorphism in the COMT gene (Val158Met, rs4680) separating high (Val/Val, COMT(HH)), intermediate (Val/Met, COMT(HL)) and low metabolizers (Met/Met, COMT(LL)). We investigated dopaminergic denervation in the striatum in PD patients according to COMT rs4680 genotype. Patients with idiopathic PD were assessed for motor severity (UPDRS-III rating scale in OFF-state), dopaminergic denervation using [123I]-FP-CIT SPECT imaging, and genotyped for the COMT rs4680 enzyme. [123I]-FP-CIT binding potential (BP) for each voxel was defined by the ratio of tracer-binding in the region of interest (striatum, caudate nucleus and putamen) to that in a region of non-specific activity. Genotyping was performed using TaqMan(®) SNP genotyping assay. We used a regression model to evaluate the effect of COMT genotype on the BP in the striatum and its sub-regions. Genotype distribution was: 11 (27.5%) COMT(HH), 26 (65%) COMT(HL) and 3 (7.5%) COMT(LL). There were no significant differences in disease severity, treatments, or motor scores between genotypes. When adjusted to clinical severity, gender and age, low and interme...Continue Reading
References
Jul 1, 1990·Trends in Neurosciences·M J ZigmondE M Stricker
Aug 1, 1984·Archives of Neurology·M J ZigmondE M Stricker
Apr 4, 1995·Biochemistry·T LottaJ Taskinen
Jun 1, 1996·Pharmacogenetics·H M LachmanR M Weinshilboum
Jun 10, 1998·Progress in Neurobiology·E Bezard, C E Gross
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·J A GogosM Karayiorgou
Apr 24, 1999·Neurology·M IchiseA E Lang
Nov 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Marko HuotariPekka T Männistö
Oct 24, 2003·Psychopharmacology·Marko HuotariPekka T Männistö
Oct 1, 2004·American Journal of Human Genetics·Jingshan ChenDaniel R Weinberger
May 16, 2006·Neurochemistry International·Christian Pifl, Oleh Hornykiewicz
Aug 21, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Aurélie KasPhilippe Remy
May 7, 2009·Molecular Psychiatry·D MierA Meyer-Lindenberg
Oct 2, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Mika M HirvonenJarmo Hietala
Jul 10, 2010·Psychopharmacology·Anne TammimäkiPekka T Männistö
Dec 18, 2010·Clinical Neuropharmacology·David MaltêteJean Costentin
Feb 22, 2011·Neuroscience·N R S GoldbergC K Meshul
Nov 15, 2011·Brain : a Journal of Neurology·Ramachandiran NandhagopalA Jon Stoessl
Mar 8, 2013·Neurology India·Lu LechunHuang Changqi
Apr 12, 2013·Neurology·Alexander StorchHeinz Reichmann
Aug 10, 2013·Medical Physics·Tingting ChangOsama R Mawlawi
May 14, 2014·Pharmacogenetics and Genomics·Félix J Jiménez-JiménezJosé A G Agúndez
Citations
Sep 23, 2016·Journal of the Neurological Sciences·Youwen ZhangYuhu Zhang
Apr 12, 2017·PloS One·Ismael HuertasPablo Mir
Mar 27, 2018·Journal of Clinical Pharmacology·Tiago Furtado SampaioPaulo Roberto Eleutério de Souza
May 19, 2018·Annals of Nuclear Medicine·Kyoungjune PakIn Joo Kim
Sep 28, 2017·The International Journal of Neuroscience·Victor MarinhoSilmar Teixeira
May 19, 2017·Frontiers in Aging Neuroscience·Jing-Ya LinZhen-Guo Liu
Nov 6, 2020·Molecular Biology Reports·Erinaldo Ubirajara Damasceno Dos SantosPaulo Roberto Eleutério de Souza
Mar 23, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Rahul GauravStéphane Lehéricy
Apr 4, 2021·Brain Sciences·Rwei-Ling YuChun-Hsiang Tan
Jul 22, 2021·Annals of Nuclear Medicine·Kyoungjune PakIn Joo Kim